Trending
Revolutionary Shows Promise 4
Revolutionary Shows Promise 3
Revolutionary Shows Promise 1
Revolutionary aids Treatment Shows Promise
Revolutionary Cancer Treatment Shows Promise
FDA Expands Approval of Vonvendi for von Willebrand Disease, Including Pediatric Use
Child Depression Fluctuations may trigger Parent Depression not vice versa: JAMA
Indoor Air Quality and Diet Found to Regulate Inflammation in Childhood: Study Finds
How Smoking Fuels Pancreatic Cancer Growth and Worsens Outcomes: Study Finds Out
Follow Us:
November 01, 2025

Get In Touch

Unique Pharma Asked To Revise BE Study Protocol for Cilnidipine-Metoprolol FDC Pharma News

Unique Pharma Asked To Revise BE Study Protocol for Cilnidipine-Metoprolol FDC

  • 22 October 2025
  • 1 week ago

High-Alcohol Oral Drugs Over 12% to Come Under Prescription-Only H1 Category, Health Ministry Drafts Rules Pharma News

High-Alcohol Oral Drugs Over 12% to Come Under Prescription-Only H1 Category, Health Ministry Drafts Rules

  • 22 October 2025
  • 1 week ago

Dr Reddy's Labs Srikakulam facility gets EIR from USFDA Pharma News

Dr Reddy's Labs Srikakulam facility gets EIR from USFDA

  • 22 October 2025
  • 1 week ago

Alembic Pharma gets USFDA okay for Triamcinolone Acetonide Injectable Suspension Pharma News

Alembic Pharma gets USFDA okay for Triamcinolone Acetonide Injectable Suspension

  • 22 October 2025
  • 1 week ago

Torrent Pharma finally gets CCI nod for acquisition of JB Chemicals Pharma News

Torrent Pharma finally gets CCI nod for acquisition of JB Chemicals

  • 22 October 2025
  • 1 week ago

AbbVie concludes acquisition of Gilgamesh Pharma Bretisilocin Pharma News

AbbVie concludes acquisition of Gilgamesh Pharma Bretisilocin

  • 21 October 2025
  • 1 week ago

Boehringer Ingelheim, AimedBio collaborate to develop ADC therapy for cancer Pharma News

Boehringer Ingelheim, AimedBio collaborate to develop ADC therapy for cancer

  • 21 October 2025
  • 1 week ago

Novo Nordisk inks pact with Omeros for clinical-stage MASP-3 inhibitor zaltenibart Pharma News

Novo Nordisk inks pact with Omeros for clinical-stage MASP-3 inhibitor zaltenibart

  • 21 October 2025
  • 1 week ago

CDSCO Panel Clears Eli Lilly's Tirzepatide for Phase IV Clinical Trial in India Pharma News

CDSCO Panel Clears Eli Lilly's Tirzepatide for Phase IV Clinical Trial in India

  • 21 October 2025
  • 1 week ago

Alkem Vs Alchem: Delhi HC Grants Interim Relief to Alkem Labs in Trademark Tussle Pharma News

Alkem Vs Alchem: Delhi HC Grants Interim Relief to Alkem Labs in Trademark Tussle

  • 21 October 2025
  • 1 week ago

Recent News

Global review links common viral infections to hig...

  • 01 November, 2025

Lower ketone levels and improved exercise capacity...

  • 01 November, 2025

Citrus Flavonoids effective nutritional adjunct to...

  • 01 November, 2025

Daily kimchi intake linked to reduced BMI and bell...

  • 01 November, 2025

Aggressive Risk Factor Management Reduces AF Recur...

  • 01 November, 2025

Daily Newsletter

Get all the top stories from Blogs to keep track.